Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Omicron sub-variant BA.2 accounts for about 55% of COVID variants in U.S. - CDC

Published 03/29/2022, 11:07 AM
Updated 03/29/2022, 11:11 AM
© Reuters. A health care worker points to a man wearing a protective face mask while waiting in line to receive one of the available first, second and booster doses of the coronavirus disease (COVID-19) vaccine at the L.A. Care Health Plan free testing and vaccinati

(Reuters) -The U.S. national public health agency said on Tuesday that BA.2 sub-variant of Omicron was estimated to account for more than half the coronavirus variants in the country.

A resurgence of COVID-19 cases in parts of Asia and Europe has raised concerns that another wave could follow in the United States, but the country's health experts believe it is unlikely.

Evercore ISI analyst Michael Newshel said the 7-day rolling average for COVID cases bottomed a week ago at just under 29,000 and has stayed at about the same level.

"There could be a modest increase in cases in the short term as more states bottom, but there are still no signs of a sharp reversal to the degree seen in many countries in Europe," Newshel said in a note.

Last week, top U.S. infectious disease official Dr Anthony Fauci said that although he does not expect a major surge, he would not be surprised to see a rise in cases owing to the increasing dominance of the BA.2 sub-variant.

The highly transmissible BA.2 sub-variant is estimated by the U.S. Centers for Disease Control and Prevention (CDC) to make up 54.9% of the COVID-19 variants in the United States, as of March 26.

BA.2 made up 39%, revised up from 34.9%, of the variants in the country for the week ended March 19, according to CDC estimates.

Most people in the United States are now considered to be in low COVID transmission, according to new CDC guidelines introduced last month that emphasized hospital capacity over case counts.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.